QuantHealth Appoints Esteemed Pharmaceutical Executives to Inaugural Advisory Board

TEL AVIV, Israel--(BUSINESS WIRE)--QuantHealth, an AI-powered clinical trial design company, today announced the formation of its inaugural Advisory Board. Founding members Michel Vounatsos, former CEO of Biogen, Rob Scott, former Chief Medical Officer for AbbVie, and Christian Hein, former VP, Global Head of Digital Transformation & Innovation Execution at Novartis, will bring their decades of pharmaceutical experience to provide strategic guidance to QuantHealth. The board members will he